Novacyt (NCYT) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free NCYT Stock Alerts GBX 56 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 22, 2024 | morningstar.comNovacyt SA ALNOVApril 23, 2024 | actusnews.comLong Term Incentive PlanApril 19, 2024 | actusnews.comDHSC Claim update - Pre-Trial ReviewApril 13, 2024 | lse.co.ukAstraZeneca increases 2024 dividend by 7%April 11, 2024 | actusnews.comDirectorate Changes and FY 23 results updateFebruary 6, 2024 | actusnews.comUpdate on Taiwanese divestmentJanuary 30, 2024 | morningstar.comNovacyt SA NYZJanuary 25, 2024 | actusnews.comTrading updateSeptember 30, 2023 | actusnews.comReminder to shareholders re. AGM votingSeptember 11, 2023 | actusnews.comCancellation of trading of Yourgene SharesAugust 29, 2023 | actusnews.comNotice of rescheduled AGMJuly 3, 2023 | proactiveinvestors.comYourgene jumps 143% on Novacyt £16.7m knock-out bidJune 24, 2023 | lse.co.ukChipotle Mexica Share ChatJune 14, 2023 | lse.co.ukNordtelekom Nyr Share ChatJune 12, 2023 | lse.co.ukCalipso Oradea Share ChatMay 26, 2023 | actusnews.comPublication of Annual Report and AGM votingJanuary 30, 2023 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date ListedJanuary 26, 2023 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading UpdateDecember 7, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director ChangeDecember 6, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA LegislationNovember 10, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate ChangeOctober 26, 2022 | proactiveinvestors.comNovacyt gains UK approval for its multiplex PCR test for detection of winter virusesOctober 26, 2022 | proactiveinvestors.comNovacyt approved for COVID and winter viruses PCR testOctober 10, 2022 | thetimes.co.ukYour three-minute digest - The TimesOctober 10, 2022 | marketscreener.comNovacyt Faces $150 Million Legal Claim For Inconsistent COVID-19 Testing Results In UK - Marketscreener.comOctober 9, 2022 | thetimes.co.ukNovacyt subject to legal claim after 'troubling' Covid test results - The TimesOctober 6, 2022 | businesswire.comOutlook on the High-Resolution Melting Analysis Global Market to 2027 - Featuring Agilent Technologies, Azura Genomics, Illumina and Novacyt Among Others - ResearchAndMarkets.com - Business WireOctober 1, 2022 | seekingalpha.comNovacyt S.A. 2022 Q2 - Results - Earnings Call Presentation (OTCMKTS:NVYTF) - Seeking AlphaSeptember 29, 2022 | morningstar.co.ukEARNINGS UPDATES: Volvere says interim performance... - MorningstarSeptember 29, 2022 | marketwatch.comNovacyt 1H Pretax Loss Narrowed Despite Major Revenue Decline - MarketWatchSeptember 29, 2022 | businesswire.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Results - Business WireSeptember 29, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 ResultsSeptember 21, 2022 | prnewswire.comRapid Plasma Reagin Test Market to observe USD 46.28 Mn incremental growth -- Driven by increasing incidence of syphilis - PR NewswireAugust 31, 2022 | law360.comUK Gov't Sues COVID-19 Test Designer For £135M - Law360August 12, 2022 | finance.yahoo.comGlobal Organ Transplant Diagnostics Market to 2031 - Featuring Abbott Laboratories, ARUP Laboratories, BAG Health Care and bioMerieux Among Others - Yahoo FinanceAugust 10, 2022 | businesswire.comOutlook on the Organ Transplant Diagnostics Global Market to 2031 - High Demand for Molecular Diagnostic Tests is Driving Growth - ResearchAndMarkets.com - Business WireAugust 6, 2022 | morningstar.co.ukTRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim - MorningstarAugust 4, 2022 | marketwatch.comNovacyt Launches New Covid-19 PCR Assays - MarketWatchAugust 4, 2022 | businesswire.comLaunch of Novacyt's first fully lyophilised PROmate® assays - Business WireJuly 28, 2022 | lse.co.ukTRADING UPDATES: Scottish American outperforms; Amte picks Dundee | Financial News - London South EastJuly 28, 2022 | businesswire.comNovacyt S.A. (“Novacyt”, the “Company” or the “Group”): Launch of Research-Use-Only Adenovirus F41 Assay - Business WireJuly 28, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Launch of Research-Use-Only Adenovirus F41 AssayJuly 21, 2022 | marketscreener.comNovacyt : Results of Annual General Meeting - Marketscreener.comJuly 15, 2022 | morningstar.co.ukAIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise - MorningstarJuly 15, 2022 | marketscreener.comNovacyt - Approval of exsig COVID-19 Direct test in the UK under CTDA legislation - Marketscreener.comJuly 15, 2022 | lse.co.ukAIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise | Financial News - London South EastJuly 15, 2022 | lse.co.ukNovacyt's exsig receives UK approval | Financial News - London South EastJuly 15, 2022 | businesswire.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of exsig™ COVID-19 Direct Test in the UK Under CTDA Legislation - Business WireJuly 9, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Trading Update and Progress Against Strategy for H1 2022 - Yahoo FinanceJuly 7, 2022 | proactiveinvestors.com.auKenmare Resources climbs after positive broker note - Proactive Investors Australia Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. NCYT Media Mentions By Week NCYT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NCYT News Sentiment▼1.380.76▲Average Medical News Sentiment NCYT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NCYT Articles This Week▼10▲NCYT Articles Average Week Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EKF Diagnostics News Creo Medical Group News Inspiration Healthcare Group News Surgical Innovations Group News Smith & Nephew News MaxCyte News Allergy Therapeutics News Arix Bioscience News hVIVO News Avacta Group News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:NCYT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBiden replacement revealed?Paradigm PressThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
